Cytomegalovirus Infection in Kidney Transplant Recipients: Evolution of Approach Through Three Eras

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3506-3508

  Boucher, A ^a   Lord, H ^a   Collette, S ^a   Morin, M ^a   Dandavino, R ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CREATININE; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY GRAFT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS; SYNTHESIS; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ACYCLOVIR; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33845389864     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.127     Document Type: Article

References (6)

1. Cytomegalovirus. Am J Transplant 4 suppl 10 (2004) 51
2. Preiksaitis J.K., Brennan D.C., Fishman J., et al. Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation: final report. Am J Transplant 5 (2005) 218
3. Cailhier J.F., Boucher A., Béliveau C., et al. CMV in kidney transplants in the tacrolimus-mycophenolate era. Transplant Proc 33 (2001) 1196
4. Sagedal S., Hartmann A., Nordial K.P., et al. Impact of early cytomegalovirus infection and disease on long term recipient and kidney graft survival. Kidney Int 66 (2004) 329
5. Strippoli G.F.M., Hodson E.M., Jones C., et al. Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 81 (2006) 139
6. Allison A.C., and Eugui E.M. Mechanisms of action of mycophenolate in preventing acute and chronic allograft rejection. Transplantation 80 (2005) S181